G935-1803 Screening compound: 1-({1-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-3,5-dimethyl-1H-pyrazol-4-yl}sulfonyl)-N-(4-methylpyridin-2-yl)piperidine-4-carboxamide

G935-1803 Screening compound: 1-({1-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-3,5-dimethyl-1H-pyrazol-4-yl}sulfonyl)-N-(4-methylpyridin-2-yl)piperidine-4-carboxamide
G935-1803 Screening compound: 1-({1-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-3,5-dimethyl-1H-pyrazol-4-yl}sulfonyl)-N-(4-methylpyridin-2-yl)piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G935-1803
1-({1-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-3,5-dimethyl-1H-pyrazol-4-yl}sulfonyl)-N-(4-methylpyridin-2-yl)piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G935-1803

Molecular Formula

C27H32N6O4S (C27 H32 N6 O4 S)

Compound Name

1-({1-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-3,5-dimethyl-1H-pyrazol-4-yl}sulfonyl)-N-(4-methylpyridin-2-yl)piperidine-4-carboxamide

IUPAC name

1-({1-[2-(23-dihydro-1H-indol-1-yl)-2-oxoethyl]-35-dimethyl-1H-pyrazol-4-yl}sulfonyl)-N-(4-methylpyridin-2-yl)piperidine-4-carboxamide

SMILES

Cc(n(CC(N(CC1)c2c1cccc2)=O)nc1C)c1S(N(CC1)CCC1C(Nc1nccc(C)c1)=O)(=O)=O

InChI

InChI=1S/C27H32N6O4S/c1-18-8-12-28-24(16-18)29-27(35)22-9-13-31(14-10-22)38(36,37)26-19(2)30-33(20(26)3)17-25(34)32-15-11-21-6-4-5-7-23(21)32/h4-8,12,16,22H,9-11,13-15,17H2,1-3H3,(H,28,29,35)

InChI Key

WFEMBGKWTLKGBT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15075965

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

536.66

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.590

Distribution Coefficient, logD

1.588

Water Solubility, LogSw

-2.67

Polar Surface Area

94.360

Acid Dissociation Constant (pKa)

10.35

Base Dissociation Constant (pKb)

4.91

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.70

G935-1803 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
Structure:
  • Mimetics
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G935-1803 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G935-1803?
Check Price and Availability of G935-1803, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G935-1803 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G935-1803
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G935-1803
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G935-1803 available by request